Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

USFDA accepts BLA for moxetumomab pasudotox by AstraZeneca

biospectrumasiaApril 08, 2018

Tag: FDA , moxetumomab pasudotox , AstraZeneca

PharmaSources Customer Service